High-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinoma

Garcia-Dios, D.Lambrechts, D.Coenegrachts, L.Vandenput, I.Capoen, A.Webb, P.Ferguson, K.Anecs,Akslen, L.Claes, B.Vergote, I.Moerman, P.Van Robays, J.Marcickiewicz, J.Salvesen, H.Spurdle, A.Amant, F.2015-10-212015-10-212013Gynecologic Oncology, 2013; 128(2):327-3340090-82581095-6859http://hdl.handle.net/2440/95511Abstract not availableenCopyright © 2012 Elsevier Inc. All rights reserved.Endometrial cancerClinical molecular geneticsMolecular biomarkersOncogenesTumor suppressor genesHigh-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinomaJournal article003001326010.1016/j.ygyno.2012.11.0370003144453000312-s2.0-84872840552151414